Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Azithromycin 500 MG Injection

Known as: AZITHROMYCIN MONOHYDRATE 2 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Azithromycin], AZITHROMYCIN DIHYDRATE 500MG/VIL INJ [VA Product], AZITHROMYCIN MONOHYDRATE 100 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Azithromycin] 
National Institutes of Health

Related topics

Related topics

29 relations
AzithromycinAzithromycin DihydrateAzithromycin MonohydrateBacterial Endocarditis
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label…
Background Malaria remains one of the most important causes of morbidity and mortality in pregnant women and their newborn babies… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
2014
2014
Development and Evaluation of a Novel Oro-Sustained Stomach Specific Floating in Situ Gelling System of Azithromycin Dihydrate
Floating drug delivery system provides the advantage of sustained release of drugs over a prolonged period of time thereby… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 4
2014
2014
Age-related decline in functional connectivity of the human vestibular cortical
Chemistry when combined with molecular imaging is extraordinary at answering questions about human brain function. Positron… Expand
2014
2014
Establishment of Bacterial Endotoxin Test for Azithromycin Lactobionate Injection
OBJECTIVE To establish a method for bacterial endotoxin test of Azithromycin Lactobionate Injection. METHODS According to ChP… Expand
2013
2013
4 "-O-(1-aralkyl-1,2,3-triazole-4-methyl-cabanaoyl) Azithromycin derivative
The invention discloses 4'-O-(1-aralkyl-1,2,3-triazole-4-methyl-formamyl) azithromycin derivatives, having a structure as shown… Expand
2012
2012
Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin.
Exceptional therapeutic effects of macrolides in treating various infections and inflammatory conditions can be significantly… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 5
  • figure 8
2008
2008
In vivo characterization of monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: A technical note
Summary and ConclusionsThe present work aimed to characterize transdermal drug delivery systems of pinacidil monohydrate in vivo… Expand
  • table 1
  • figure 1
2008
2008
Purulent Bacterial Conjunctivitis: Bacteriological Efficacy of 3-Days 1.5% Azithromycin Dihydrate Eye Drop Solution (azith) versus 7 Days of Tobramycin (tobra) 0.3 %
Highly Cited
2007
Highly Cited
2007
Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea.
  • J. Fowler
  • Journal of drugs in dermatology : JDD
  • 2007
    • Corpus ID: 33979210
Research into the pathophysiology of rosacea suggests a central role for inflammatory mediators such as nitric oxide (NO… Expand
Highly Cited
2002
Highly Cited
2002
Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterisation.
  • M. Aqil, Asgar Ali
  • European journal of pharmaceutics and…
  • 2002
    • Corpus ID: 33457921
The monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate (PM) were prepared by film casting… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE